FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lupin Pharmaceuticals Voriconazole for Oral Suspension Recall

Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted

Lupin Pharmaceuticals Inc. · Baltimore, MD

Risk level
Class II
Reported by FDA
Feb 28, 2024
Recall ID
D-0337-2024
Check your lot numberHow we source this data

Summary

Lupin Pharmaceuticals recalled Voriconazole for Oral Suspension starting Feb 5, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0337-2024 on Feb 28, 2024. Reason: Labeling: Incorrect or Missing Package Insert. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Package Insert

Product description

Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the bottle to release the powder. Add 50mL of water to the bottle and shake vigorously for 1 minute. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202. NDC: 43386-038-60.

Lot numbers, UPCs & expiration codes

Lot#: S200756; Exp. 10/2024 Lot#: S300218; Exp. 04/2025 Lot#: S300633; Exp. 09/2025

Where it was sold

OH, IL, NJ

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0337-2024
Classification
Class II
Status
Terminated
Recall initiated
Feb 5, 2024
FDA report date
Feb 28, 2024
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Lupin Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-0337-2024, exactly as published.

Show all FDA fields
City
Baltimore
State
MD
Status
Terminated
Country
United States
Event ID
93934
Address
Harborplace Tower
Address (line 2)
111 S Calvert St Fl 21st
Code information
Lot#: S200756; Exp. 10/2024 Lot#: S300218; Exp. 04/2025 Lot#: S300633; Exp. 09/2025
Postal code
21202-6174
Report date
Feb 28, 2024
Product type
Drugs
Recall number
D-0337-2024
Classification
Class II
Recalling firm
Lupin Pharmaceuticals Inc.
Termination date
Dec 27, 2024
Reason for recall
Labeling: Incorrect or Missing Package Insert
Voluntary / mandated
Voluntary: Firm initiated
Product description
Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the bottle to release the powder. Add 50mL of water to the bottle and shake vigorously for 1 minute. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202. NDC: 43386-038-60.
Distribution pattern
OH, IL, NJ
Recall initiation date
Feb 5, 2024
Initial firm notification
E-Mail
Center classification date
Feb 16, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0337-2024, published Feb 28, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls